Cargando…
Benchmarking biopharmaceutical process development and manufacturing cost contributions to R&D
This study aims to benchmark and analyze the process development and manufacturing costs across the biopharmaceutical drug development cycle and their contribution to overall research and development (R&D) costs. This was achieved with a biopharmaceutical drug development lifecycle cost model th...
Autores principales: | Farid, Suzanne S., Baron, Max, Stamatis, Christos, Nie, Wenhao, Coffman, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531566/ https://www.ncbi.nlm.nih.gov/pubmed/32449439 http://dx.doi.org/10.1080/19420862.2020.1754999 |
Ejemplares similares
-
Biopharmaceutical benchmarks 2022
por: Walsh, Gary, et al.
Publicado: (2022) -
Closed-loop optimization of chromatography column sizing strategies in biopharmaceutical manufacture
por: Allmendinger, Richard, et al.
Publicado: (2014) -
End‐to‐end collaboration to transform biopharmaceutical development and manufacturing
por: Erickson, John, et al.
Publicado: (2021) -
On-demand manufacturing of clinical-quality biopharmaceuticals
por: Crowell, Laura E., et al.
Publicado: (2018) -
Developments and opportunities in continuous biopharmaceutical manufacturing
por: Khanal, Ohnmar, et al.
Publicado: (2021)